Skip to main content

UNGA 2020: Mohammed harps on need to harness multilateralism to recover from COVID-19

UNGA 2020: Mohammed harps on need to harness multilateralism to recover from COVID-19

By Ebunoluwa Sessou

The UN Deputy Secretary-General, Amina Mohammed has harped on the need to harness multilateralism and partnership with the vision to change the narrative, saying keeping momentum for maternal and child health and recovery strongly from the COVID-19 pandemic; should be the focus on the universal health coverage that strengthens accountability and investing wisely.

In a statement during a virtual event for the launch the programme to mark the 10-year anniversary of Every Woman, Every Child, on the theme, “Protect the Progress- Rise, Refocus, Recover:  The 2020 Progress Report on the Every Woman, Every Child Global Strategy for Women’s, Children’s and Adolescents’ Health”, Mohammed stated that the return on the investment and its positive ripple effect will be transformational for families, communities and societies at large.

According to her, Women and children are the faces of the Decade of Action ahead.  “In 2030, we will judge our success in delivering the Sustainable Development Goals by the lives we have saved and transformed.  The need to harness the positive power of multilateralism and partnership with a common vision for change has never been more urgent”.

READ ALSO: Senate mulls N5m fine for illegal drone construction

“There is no time to lose.  Let us commit to the challenge of protecting our progress. We have heard of the successes since its launch:  steep declines in global maternal and child mortality, 1 billion children vaccinated, and millions of child marriages prevented.  These could not have been achieved without this global partnership”.

“But our gains have proven fragile, amid the COVID-19 pandemic, deadly conflicts and the existential threat of the climate crisis.  Leaders everywhere are focused on fighting the pandemic while trying to keep societies strong and resilient.  As we search for solutions, we must take a broad view”.

Adding that women and children are the foundation of the communities and the future, she stressed that plans to respond to and recover from COVID-19 must prioritize their rights and ensure continued access to services that support health, access to clean water, nutrition, and education.

“While much is still unknown and uncertain, our collective goal endures:  for women, children, and adolescents everywhere to survive and thrive, and for their lives to be transformed.  Today, I call on each of you to join the Secretary-General in refocusing our efforts to usher in a decade of ambitious action to protect progress for every woman, child, and adolescent, everywhere”, she added

Vanguard

The post UNGA 2020: Mohammed harps on need to harness multilateralism to recover from COVID-19 appeared first on Vanguard News.


by Lawal Sherifat via Vanguard News https://ift.tt/2G6f7Hv Best Known Member of the Cabinet Wikipedia
Labels:

Comments

Post a Comment

Popular posts from this blog

Effective Data Governance: IIM-Africa inks partnership deal with Data Management University

President/Chairman of the governing council of IIM-Africa, Dr. Oyedokun Oyewole has said that effective data governance strategy has become more essential for the survival and sustenance of government and businesses, especially with the sudden outbreak of COVID-19 Pandemic. Oyewole said there is the need to ensure that the right policies, processes, technology, and people are in place to effectively manage data while complying with legal and regulatory requirements. He said that as part of the IIM Africa’s commitments towards ensuring global best practices, it has entered into a long-term partnership with DataManagementU.com to bring the finest data management training to industries across Africa. READ ALSO:  COVID-19: Foreign affairs minister says first set of Nigerians abroad to be evacuated soon According to the IIM President, the alliance is expected to provide members of the Institute and other professionals across Africa, high standards, internationally-recognized learn...
Post a Comment
Read more

Naomi Osaka’s statement about withdrawing from French Open

Japan’s Naomi Osaka returns the ball to Romania’s Patricia Maria Tig during their first round match of the French open tennis tournament at the Roland Garros stadium Sunday, May 30, 2021 in Paris. (AP Photo/Christophe Ena) Naomi Osaka tweeted the following statement announcing her withdrawal from the French Open on Monday: “Hey everyone, this isn’t a situation I ever imagined or intended when I posted a few days ago. I think now the best thing for the tournament, the other players and my well-being is that I withdraw so that everyone can get back to focusing on the tennis going on in Paris. ”I never wanted to be a distraction and I accept that my timing was not idea and my message could have been clearer. ”More importantly I would never trivialize mental health or use the term lightly. The truth is that I have suffered long bouts of depression since the US Open in 2018 and I have had a really hard time coping with that. Anyone that knows me knows I’m introverted, and anyone tha...
Post a Comment
Read more

Remdesivir: The COVID-19 drug helping patients recover faster

A vial of the investigational drug remdesivir is visually inspected at a Gilead manufacturing site in the United States. PHOTO: AP Remdesivir has been shown to speed up recovery times for patients with COVID-19 in a major US-led trial, becoming the first drug with proven benefit against the disease. Here is what you need to know. – What is remdesivir? – Remdesivir is an experimental, broad spectrum antiviral made by US pharmaceutical Gilead Sciences that was first developed to treat Ebola, a viral hemorrhagic fever. It showed early promise in a primate study in 2016 and was later rolled out for a major trial in the Democratic Republic of Congo, where it was compared against three other medicines. That study concluded in 2019 when it was discontinued because it did not boost survival rates as greatly as two monoclonal antibody drugs, which are lab-engineered immune system proteins. In February, the US National Institute of Allergy and Infectious Diseases (NIAID) announced ...
Post a Comment
Read more